Functional studies of 18 heterologously expressed medium-chain acyl-CoA dehydrogenase (MCAD) variants

Journal of Inherited Metabolic Disease

Volumn 37, Issue 6, 2014, Pages 917-928

  Koster, Kira Lee ^a   Sturm, Marga ^a   Herebian, Diran ^a   Smits, Sander H J ^b   Spiekerkoetter, Ute ^c  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; OLIGOMER; PROTEIN VARIANT; ACYL COENZYME A; ACYL COENZYME A DEHYDROGENASE; FLAVINE ADENINE NUCLEOTIDE; OCTANOYL-COENZYME A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS LINKING; ENZYME ACTIVITY; ENZYME SPECIFICITY; GENE MUTATION; HETEROLOGOUS EXPRESSION; HUMAN; NONHUMAN; OXIDATION; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TEMPERATURE SENSITIVITY; WESTERN BLOTTING; DEFICIENCY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ESCHERICHIA COLI; GENETICS; GENOTYPE; METABOLISM; MUTATION; NEWBORN; NEWBORN SCREENING; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PROTEIN TERTIARY STRUCTURE;

ACYL COENZYME A; ACYL-COA DEHYDROGENASE; DNA MUTATIONAL ANALYSIS; ESCHERICHIA COLI; FLAVIN-ADENINE DINUCLEOTIDE; GENOTYPE; HUMANS; INFANT, NEWBORN; LIPID METABOLISM, INBORN ERRORS; MUTATION; NEONATAL SCREENING; OXIDATION-REDUCTION; PROTEIN STRUCTURE, TERTIARY; SUBSTRATE SPECIFICITY;

EID: 84911995156     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-014-9732-5     Document Type: Article

References (37)

1. Andresen BS, Bross P, Udvari S et al (1997) The molecular basis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in compound heterozygous patients: is there correlation between genotype and phenotype? Hum Mol Genet 6(5):695–707
2. Andresen BS, Dobrowolski SF, O’Reilly L et al (2001) Medium-chain acyl-CoA dehydrogenase (MCAD) mutations identified by MS/MS-based prospective screening of newborns differ from those observed in patients with clinical symptoms: identification and characterization of a new, prevalent mutation that results in mild MCAD deficiency. Am J Hum Genet 68(6):1408–1418
3. Arnold GL, Saavedra-Matiz CA, Galvin-Parton PA et al (2010) Lack of genotype-phenotype correlations and outcome in MCAD deficiency diagnosed by newborn screening in New York State. Mol Genet Metab 99(3):263–268
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
5. Bross P, Engst S, Strauss AW, Kelly DP, Rasched I, Ghisla S (1990) Characterization of wild-type and an active site mutant of human medium chain acyl-CoA dehydrogenase after expression in Escherichia coli. J Biol Chem 265(13):7116–7119
6. Bross P, Jespersen C, Jensen TG et al (1995) Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly, and stability of MCAD enzyme. J Biol Chem 270(17):10284–10290
7. Chohan KK, Jones M, Grossmann JG, Frerman FE, Scrutton NS, Sutcliffe MJ (2001) Protein dynamics enhance electronic coupling in electron transfer complexes. J Biol Chem 276(36):34142–34147
8. Cornelius N, Frerman FE, Corydon TJ et al (2012) Molecular mechanisms of riboflavin responsiveness in patients with ETF-QO variations and multiple acyl-CoA dehydrogenation deficiency. Hum Mol Genet 21(15):3435–3448
9. Dessein AF, Fontaine M, Andresen BS et al (2010) A novel mutation of the ACADM gene (c.145C > G) associated with the common c.985A > G mutation on the other ACADM allele causes mild MCAD deficiency: a case report. Orphanet J Rare Dis 5:26
10. Frerman FE (1988) Acyl-CoA dehydrogenases, electron transfer flavoprotein and electron transfer flavoprotein dehydrogenase. Biochem Soc Trans 16(3):416–418
11. Gobin-Limballe S, McAndrew RP, Djouadi F, Kim JJ, Bastin J (2010) Compared effects of missense mutations in Very-Long-Chain Acyl-CoA dehydrogenase deficiency: combined analysis by structural, functional and pharmacological approaches. Biochim Biophys Acta 1802(5):478–484
12. Gregersen N, Bross P, Andresen BS (2004) Genetic defects in fatty acid beta-oxidation and acyl-CoA dehydrogenases. Molecular pathogenesis and genotype-phenotype relationships. Eur J Biochem FEBS 271(3):470–482
13. Gregersen N, Andresen BS, Pedersen CB, Olsen RK, Corydon TJ, Bross P (2008) Mitochondrial fatty acid oxidation defects–remaining challenges. J Inherit Metab Dis 31(5):643–657
14. Grosse SD, Khoury MJ, Greene CL, Crider KS, Pollitt RJ (2006) The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update. Genet Med Off J Am Coll Med Genet 8(4):205–212
15. Keyser B, Muhlhausen C, Dickmanns A et al (2008) Disease-causing missense mutations affect enzymatic activity, stability and oligomerization of glutaryl-CoA dehydrogenase (GCDH). Hum Mol Genet 17(24):3854–3863
16. Lee HJ, Wang M, Paschke R, Nandy A, Ghisla S, Kim JJ (1996) Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity. Biochemistry 35(38):12412–12420
17. Liebig M, Schymik I, Mueller M et al (2006) Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels. Pediatrics 118(3):1065–1069
18. Maier EM, Gersting SW, Kemter KF et al (2009) Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening. Hum Mol Genet 18(9):1612–1623
19. Matsubara Y, Narisawa K, Miyabayashi S et al (1990) Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Biochem Biophys Res Commun 171(1):498–505
20. McKinney JT, Longo N, Hahn SH et al (2004) Rapid, comprehensive screening of the human medium chain acyl-CoA dehydrogenase gene. Mol Genet Metab 82(2):112–120
21. Nichols MJ, Saavedra-Matiz CA, Pass KA, Caggana M (2008) Novel mutations causing medium chain acyl-CoA dehydrogenase deficiency: under-representation of the common c.985 A > G mutation in the New York state population. Am J Med Genet A 146A(5):610–619
22. O’Reilly L, Bross P, Corydon TJ et al (2004) The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitive. Eur J Biochem FEBS 271(20):4053–4063
23. Purevsuren J, Kobayashi H, Hasegawa Y et al (2009) A novel molecular aspect of Japanese patients with medium-chain acyl-CoA dehydrogenase deficiency (MCADD): c.449-452delCTGA is a common mutation in Japanese patients with MCADD. Mol Genet Metab 96(2):77–79
24. Rhead WJ (2006) Newborn screening for medium-chain acyl-CoA dehydrogenase deficiency: a global perspective. J Inherit Metab Dis 29(2–3):370–377
25. Schatz UA, Ensenauer R (2010) The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population. J Inherit Metab Dis 33(5):513–520
26. Schmiesing J, Schluter H, Ullrich K, Braulke T, Muhlhausen C (2014) Interaction of glutaric aciduria type 1-related glutaryl-CoA dehydrogenase with mitochondrial matrix proteins. PLoS One 9(2):e87715
27. Smith EH, Thomas C, McHugh D et al (2010) Allelic diversity in MCAD deficiency: the biochemical classification of 54 variants identified during 5 years of ACADM sequencing. Mol Genet Metab 100(3):241–250
28. Sturm M, Herebian D, Mueller M, Laryea MD, Spiekerkoetter U (2012) Functional effects of different medium-chain acyl-CoA dehydrogenase genotypes and identification of asymptomatic variants. PLoS One 7(9):e45110
29. Swigonova Z, Mohsen AW, Vockley J (2009) Acyl-CoA dehydrogenases: dynamic history of protein family evolution. J Mol Evol 69(2):176–193
30. Tanaka K, Gregersen N, Ribes A et al (1997) A survey of the newborn populations in Belgium, Germany, Poland, Czech Republic, Hungary, Bulgaria, Spain, Turkey, and Japan for the G985 variant allele with haplotype analysis at the medium chain Acyl-CoA dehydrogenase gene locus: clinical and evolutionary consideration. Pediatr Res 41(2):201–209
31. ter Veld F, Mueller M, Kramer S et al (2009) A novel tandem mass spectrometry method for rapid confirmation of medium- and very long-chain acyl-CoA dehydrogenase deficiency in newborns. PLoS One 4(7):e6449
32. Toogood HS, van Thiel A, Basran J, Sutcliffe MJ, Scrutton NS, Leys D (2004) Extensive domain motion and electron transfer in the human electron transferring flavoprotein.medium chain Acyl-CoA dehydrogenase complex. J Biol Chem 279(31):32904–32912
33. Yokota I, Indo Y, Coates PM, Tanaka K (1990) Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. an A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. J Clin Invest 86(3):1000–1003
34. Yokota I, Coates PM, Hale DE, Rinaldo P, Tanaka K (1991) Molecular survey of a prevalent mutation, 985A-to-G transition, and identification of five infrequent mutations in the medium-chain Acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. Am J Hum Genet 49(6):1280–1291
35. Yusupov R, Finegold DN, Naylor EW, Sahai I, Waisbren S, Levy HL (2010) Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening. Mol Genet Metab 101(1):33–39
36. Ziadeh R, Hoffman EP, Finegold DN et al (1995) Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: neonatal screening shows high incidence and unexpected mutation frequencies. Pediatr Res 37(5):675–678
37. Zschocke J, Schulze A, Lindner M et al (2001) Molecular and functional characterisation of mild MCAD deficiency. Hum Genet 108(5):404–408